Sun Pharma to buy out the rest of Taro's ownership
Generics company Sun Pharma will convert its majority ownership of Israel’s Taro Pharmaceutical Industries into a full takeover of the company, buying up the shares it doesn’t own.
Sun Pharma, which says it’s the largest pharma company in India, will pay $43 each in cash for the shares of Taro that it doesn’t already own. The merger is expected to complete in the first half of this year, and Taro will become a privately-owned company that’s no longer listed on the NYSE.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
